Reference
Yoshihiro T, et al. Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer. International Journal of Clinical Oncology 24: 508-515, No. 5, May 2019. Available from: URL: http://doi.org/10.1007/s10147-018-01391-w - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1753, 40 (2019). https://doi.org/10.1007/s40278-019-61932-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-61932-5